Fig 1.
PRISMA Flow Chart Depicting Stages of Article Selection [21].
HAT hepatic artery based therapy.
Table 1.
Demographic Summary of the Studies Included for Meta-analysis.
Table 2.
Survival Outcomes (median survival in months) of HAI, RE and TACE Stratified into Appropriate Subgroups for Comparison.
Table 3.
Summary of Response Rates (Complete and Partial) of HAI, RE and TACE Stratified into Appropriate Subgroups for Comparison.
Fig 2.
Distribution of Toxicity (Events per 100 Patients) Reported Across HAI, RE and TACE.
HAI hepatic arterial infusion; RE radioembolization; TACE transcatheter chemoembolization; HAT hepatic artery based therapy; Sys concurrent systemic chemotherapy.